8,300 Shares in Walgreens Boots Alliance Inc (WBA) Purchased by Caxton Associates LP

Caxton Associates LP bought a new stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the third quarter, Holdings Channel reports. The firm bought 8,300 shares of the pharmacy operator’s stock, valued at approximately $641,000.

Other large investors also recently added to or reduced their stakes in the company. Hudock Capital Group LLC increased its position in Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 6 shares during the last quarter. Northern Capital Management LLC increased its position in Walgreens Boots Alliance by 0.4% during the second quarter. Northern Capital Management LLC now owns 6,635 shares of the pharmacy operator’s stock worth $520,000 after buying an additional 25 shares during the last quarter. MAI Capital Management increased its position in Walgreens Boots Alliance by 0.6% during the second quarter. MAI Capital Management now owns 5,272 shares of the pharmacy operator’s stock worth $413,000 after buying an additional 34 shares during the last quarter. Truepoint Inc. increased its position in Walgreens Boots Alliance by 0.5% during the second quarter. Truepoint Inc. now owns 8,614 shares of the pharmacy operator’s stock worth $698,000 after buying an additional 39 shares during the last quarter. Finally, Girard Partners LTD. increased its position in Walgreens Boots Alliance by 1.9% during the second quarter. Girard Partners LTD. now owns 3,053 shares of the pharmacy operator’s stock worth $239,000 after buying an additional 56 shares during the last quarter. 61.18% of the stock is currently owned by institutional investors and hedge funds.

Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $75.38 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. The stock has a market capitalization of $74,600.00, a P/E ratio of 20.82, a P/E/G ratio of 1.29 and a beta of 1.22. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.01. The business had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.10 earnings per share. research analysts predict that Walgreens Boots Alliance Inc will post 5.59 EPS for the current year.

Walgreens Boots Alliance announced that its board has authorized a stock repurchase program on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board of directors believes its shares are undervalued.

In related news, Director John Anthony Lederer purchased 20,000 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The stock was acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. Insiders own 14.80% of the company’s stock.

WBA has been the topic of several research reports. Needham & Company LLC decreased their target price on Walgreens Boots Alliance to $86.00 and set a “buy” rating on the stock in a research report on Wednesday, November 22nd. Jefferies Group set a $93.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Sunday, October 29th. Pivotal Research set a $73.00 target price on Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Friday, January 5th. Vetr raised Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 12th. Finally, BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, November 10th. Nine equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $86.15.

ILLEGAL ACTIVITY NOTICE: This story was reported by Community Financial News and is the property of of Community Financial News. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.com-unik.info/2018/01/12/8300-shares-in-walgreens-boots-alliance-inc-wba-purchased-by-caxton-associates-lp.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

What are top analysts saying about Walgreens Boots Alliance? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Walgreens Boots Alliance and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit